Angela McLean
Angela McLean
Unknown affiliation
Verified email at zoo.ox.ac.uk
Title
Cited by
Cited by
Year
Theoretical ecology: principles and applications
RMCMAR McLean
Oxford University Press on Demand, 2007
17502007
Lifespan of human lymphocyte subsets defined by CD45 isoforms
CA Michie, A McLean, C Alcock, PCL Beverley
Nature 360 (6401), 264-265, 1992
8391992
Response of naive and memory CD8+ T cells to antigen stimulation in vivo
H Veiga-Fernandes, U Walter, C Bourgeois, A McLean, B Rocha
Nature immunology 1 (1), 47-53, 2000
6452000
Antigenic diversity thresholds and the development of AIDS
MA Nowak, RM Anderson, AR McLean, TF Wolfs, J Goudsmit, RM May
Science 254 (5034), 963-969, 1991
6371991
The intrinsic transmission dynamics of tuberculosis epidemics
SM Blower, AR Mclean, TC Porco, PM Small, PC Hopewell, MA Sanchez, ...
Nature medicine 1 (8), 815-821, 1995
5971995
Persistent HIV-1 replication maintains the tissue reservoir during therapy
R Lorenzo-Redondo, HR Fryer, T Bedford, EY Kim, J Archer, SLK Pond, ...
Nature 530 (7588), 51-56, 2016
5442016
A restatement of the natural science evidence base concerning neonicotinoid insecticides and insect pollinators
HCJ Godfray, T Blacquiere, LM Field, RS Hails, G Petrokofsky, SG Potts, ...
Proceedings of the Royal Society B: Biological Sciences 281 (1786), 20140558, 2014
4212014
Viral dynamics of acute HIV-1 infection
SJ Little, AR McLean, CA Spina, DD Richman, DV Havlir
The Journal of experimental medicine 190 (6), 841-850, 1999
3821999
In vivo estimates of division and death rates of human T lymphocytes.
AR Mclean, CA Michie
Proceedings of the National Academy of Sciences 92 (9), 3707-3711, 1995
3541995
Possible demographic consequences of AIDS in developing countries
RM Anderson, RM May, AR Mclean
Nature 332 (6161), 228-234, 1988
2741988
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection
A Oxenius, DA Price, HF Günthard, SJ Dawson, C Fagard, L Perrin, ...
Proceedings of the National Academy of Sciences 99 (21), 13747-13752, 2002
2662002
Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco
SM Blower, AR McLean
Science 265 (5177), 1451-1454, 1994
2651994
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection
C Fagard, A Oxenius, H Günthard, F Garcia, M Le Braz, G Mestre, ...
Archives of internal medicine 163 (10), 1220-1226, 2003
2122003
Imperfect vaccines and herd immunity to HIV
AR McLean, SM Blower
Proceedings of the Royal Society of London. Series B: Biological Sciences …, 1993
2091993
Measles in developing countries. Part II. The predicted impact of mass vaccination
AR McLean, RM Anderson
Epidemiology & Infection 100 (3), 419-442, 1988
2091988
Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids
A San Millan, R Peña-Miller, M Toll-Riera, ZV Halbert, AR McLean, ...
Nature communications 5 (1), 1-11, 2014
1852014
A restatement of recent advances in the natural science evidence base concerning neonicotinoid insecticides and insect pollinators
HCJ Godfray, T Blacquiere, LM Field, RS Hails, SG Potts, NE Raine, ...
Proceedings of the Royal Society B: Biological Sciences 282 (1818), 20151821, 2015
1822015
Inefficient cytotoxic T lymphocyte–mediated killing of HIV-1–infected cells in vivo
B Asquith, CTT Edwards, M Lipsitch, AR McLean
PLoS biology 4 (4), e90, 2006
1792006
Infectious disease dynamics: what characterizes a successful invader?
RM May, S Gupta, AR McLean
Philosophical Transactions of the Royal Society of London. Series B …, 2001
1632001
Mathematical models of vaccination
A Scherer, A McLean
British Medical Bulletin 62 (1), 187-199, 2002
1622002
The system can't perform the operation now. Try again later.
Articles 1–20